Form SC 13G/A Sarepta Therapeutics, Filed by: SUSQUEHANNA SECURITIES

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/12/2026

1. HUM
2. SPCX
3. ALHC
4. PEP
5. T
6. TMUS
7. AXP
8. DAL
9. VZ
10. SPY

Go back to Form SC 13G/A Sarepta Therapeutics, Filed by: SUSQUEHANNA SECURITIES

Sarepta Therapeutics (SRPT) U.K.-Specific Hold Concerns 'Overblown' - William Blair

February 9, 2018 11:51 AM EST

William Blair analyst Tim Lugo came out to deafened Sarepta Therapeutics (NASDAQ: SRPT) following reports of a U.K.-specific hold on further dosing of patients enrolled in Sareptas global Phase III ESSENCE trial of golodirsen.

Lugo sees the concerns as "overblown".

To wit... "We see todays roughly 6% sell-off... More